go 6976 has been researched along with Leukemia in 2 studies
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, A | 1 |
| Ookura, M | 1 |
| Zokumasu, K | 1 |
| Ueda, T | 1 |
| Kelly, ML | 1 |
| Tang, Y | 1 |
| Rosensweig, N | 1 |
| Clejan, S | 1 |
| Beckman, BS | 1 |
2 other studies available for go 6976 and Leukemia
| Article | Year |
|---|---|
Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1.
Topics: Acute Disease; Apoptosis; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Resp | 2014 |
Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.
Topics: Apoptosis; Carbazoles; Enzyme Inhibitors; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Le | 1998 |